Evidence map›Paper›PMID 12885901›Full record

ArticleJournal of virology2003

Feline immunodeficiency virus ORF-Ais required for virus particle formation and virus infectivity.

Malou C Gemeniano, Earl T Sawai, Christian M Leutenegger, Ellen E Sparger

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Molecular mechanisms of FIV infection.Veterinary immunology and immunopathology · 2008
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Malou C GemenianoDepartment of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, California 95616, USA.
Earl T Sawai
Christian M Leutenegger
Ellen E Sparger
University of California Davis Medical Center · US

Funding

INFECTION AND IMMUNITY WITH FIV MUTANT PROVIRUSESR01AI040896 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI SPARGER, ELLEN ELIZABETH · 1997 to 2004
$1.4M
PATHOGENIC CONVERSION OF ATTENUATED SIV VACCINESR01AI046145 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI SAWAI, EARL T · 2000 to 2003
$1.2M
CHARACTERIZING ESSENTIAL DOMAINS IN ORFA OF FIVF31GM019259 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI GEMENIANO, MARIA L · 1997 to 2001
$40k
INTERACTIONS OF FIV ORF-A GENE AND AIDS PATHOGENESISR21AI046276 · NIAID · UNIVERSITY OF CALIFORNIA DAVIS · PI SPARGER, ELLEN ELIZABETH · 1999 to 1999
–
NIAID NIH HHS R01 AI040896NIAID NIH HHS R01 AI046145NIAID NIH HHS R01AI40896NIAID NIH HHS R01AI46145-01A2NIAID NIH HHS R21AI46276NIGMS NIH HHS 5 F31 GM19259-03NIGMS NIH HHS F31 GM019259
6 · The paper itself

Abstract

The orf-A (orf-2) gene of feline immunodeficiency virus (FIV) is a small open reading frame predicted to encode a 77-amino-acid protein that contains putative domains similar to those of the ungulate lentiviral Tat protein. Orf-A is reported to be critical for efficient viral replication in vitro and in vivo. A series of FIV-pPPR-derived proviruses with in-frame deletions and point mutations within orf-A were constructed and tested for replication in feline lymphoid cells. Orf-A mutant proviruses were also tested for viral gene and protein expression, viral particle formation, and virion infectivity. Deletions within orf-A severely restricted FIV replication in feline peripheral blood mononuclear cells (PBMC) and interleukin-2-dependent T-cell lines. In addition, substitutions of alanines for leucines in the putative leucine-rich domain, for cysteines in the putative cysteine-rich domain, and for a tryptophan at position 43 in Orf-A restricted the replication of FIV mutants. Deletions and point mutations in orf-A imposed a small effect or no effect on FIV long-terminal-repeat-driven viral gene expression and had no effect on viral protein expression. However, release of cell-free, virion-associated viral RNA in supernatants from cells transfected with orf-A mutant proviruses was severely restricted but was rescued by cotransfection with a wild-type Orf-A expression vector. In addition, virions derived from orf-A mutant proviruses expressed reduced infectivity for feline PBMC. Our findings suggest that Orf-A functions involve multiple steps of the FIV life cycle including both virion formation and infectivity. Furthermore, these observations suggest that Orf-A represents an FIV-encoded analog more similar to the accessory gene vpr, vpu, or nef than to the regulatory gene tat encoded by the primate lentiviruses.

Indexed as

Genes, ViralAnimalsBase SequenceCell LineDNA PrimersGreen Fluorescent ProteinsImmunodeficiency Virus, FelineLuminescent ProteinsOpen Reading FramesRNA, MessengerVirionVirus ReplicationDNA PrimersGreen Fluorescent ProteinsLuminescent ProteinsRNA, Messenger

Identifiers

PMID12885901
PMCPMC167212
OpenAlexW2169666646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.